Literature DB >> 3283173

Immunohistological determination of proliferative activity in seminomas.

W Düe1, K P Dieckmann, V Loy.   

Abstract

The proliferative activity and growth pattern of 20 seminomas were determined immunohistologically with the monoclonal antibody Ki-67. A growth fraction of tumour cells between 50 and 80% was found in seminomas with an almost even distribution of proliferating cells in all sections, regardless of tumour size. There was a slight tendency towards a greater growth fraction in tumours at an advanced histopathological stage. No positive correlation could be found between growth fraction and tumour size or lymphocytic infiltration. The results confirm the well known sensitivity of seminomas to radiation and chemotherapy and show that the determination of proliferative activity should be included in the histopathological routine diagnosis of malignant tumours with regard to systemic treatment and prognosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283173      PMCID: PMC1141429          DOI: 10.1136/jcp.41.3.304

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Proliferation of human testicular tumours.

Authors:  H M Rabes
Journal:  Int J Androl       Date:  1987-02

Review 2.  Pathology of germ cell tumors of testis: a progress report.

Authors:  F K Mostofi
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

Review 3.  Proliferation-dependent cytotoxicity of anticancer agents: a review.

Authors:  F Valeriote; L van Putten
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

4.  Epidemiology of testicular tumours.

Authors:  J A Waterhouse
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

5.  The management of testicular seminomas, 1979.

Authors:  W L Caldwell; M T Kademian; Z Frias; T E Davis
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

6.  Growth rate and radiosensitivity of human tumours. II. Radiosensitivity of human tumours.

Authors:  K Breur
Journal:  Eur J Cancer       Date:  1966-06       Impact factor: 9.162

7.  Analysis of proliferative compartments in human tumors. II. Seminoma.

Authors:  H M Rabes; N Schmeller; A Hartmann; U Rattenhuber; P Carl; G Staehler
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

Review 8.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

9.  Chemotherapy of disseminated testicular cancer. A random prospective study.

Authors:  L H Einhorn; S D Williams
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

10.  Testicular seminoma in Denmark 1976-1980. Results of treatment.

Authors:  H P Schultz; H von der Maase; M Rørth; M Pedersen; E Sandberg Nielsen; S Walbom-Jørgensen
Journal:  Acta Radiol Oncol       Date:  1984
View more
  6 in total

1.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

2.  Evidence of interepithelial seminoma spread into the rete testis by immunostaining of paraffin sections with antibodies against cytokeratin and vimentin.

Authors:  W Düe; V Loy
Journal:  Urol Res       Date:  1988

3.  A comparative study of cell proliferation markers in breast carcinomas.

Authors:  A S Leong; S Vinyuvat; C Suthipintawong; J Milios
Journal:  Clin Mol Pathol       Date:  1995-04

4.  Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma.

Authors:  D C Brown; K C Gatter
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

5.  Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistance.

Authors:  T Licht; K J Bross; H H Fiebig; K Schötta; D P Berger; C Dreher; G W Löhr; F Herrmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.

Authors:  A Pich; R Ponti; G Valente; L Chiusa; M Geuna; D Novero; G Palestro
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.